Virbac Group - Company Profile
Powered by
All the data and insights you need on Virbac Group in one report.
- Save hours of research time and resources with
our up-to-date Virbac Group Strategy Report
- Understand Virbac Group position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Virbac Group (Virbac) develops and produces vaccines and medicines for domestic animals and livestock. Focus on R&D, operational network and core segment: companion animals are its major strengths, even as dependence on third parties and decline in working capital is a cause for concern. However, strategic agreements and approvals, growing veterinary market and strategic initiatives could present growth opportunities to the company. Uncertain R&D outcomes, highly competitive market and government regulations could hamper Virbac’s business, operating results and financial position.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer